Synaptogenix, Inc.

Share · US87167T3005 · TAOX (XNAS)

Overview

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Synaptogenix, Inc.

No Price

29.04.2026 19:33

Current Prices from Synaptogenix, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
IEX	TAOX	USD	29.04.2026 19:33	4,89 USD	-0,17 USD -3,27 %
NASDAQ	TAOX	USD	29.04.2026 19:16	4,90 USD	-0,15 USD -2,97 %

Share Float & Liquidity

Free Float 96,68 %

Shares Float 3,18 M

Shares Outstanding 3,29 M

Company Profile for Synaptogenix, Inc. Share

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

Company Data

Name Synaptogenix, Inc.

Company TAO Synergies Inc.

Symbol TAOX

Website https://www.synaptogen.com

Primary Exchange

NASDAQ

ISIN US87167T3005

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Joshua N. Silverman

Market Capitalization 11 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1185 Avenue of the Americas, 3rd Floor, 10036 New York

IPO Date 2025-07-02

Stock Splits

Date	Split
05.04.2024	1:25

ID Changes

Date	From	To
01.07.2025	SNPX	TAOX

Ticker Symbols

Name	Symbol
NASDAQ	TAOX

More Shares

Investors who hold Synaptogenix, Inc. also have the following shares in their portfolio:

GLOBAL SHORT-TERM BOND INDEX FUND - INSTITUTIONAL PLUS CHF HEDGED ACC Fund

public stock company VSMPO-AVISMA Corporation Share